News

How Private Equity Hurts the Healthcare Workforce

Theodosia Stavroulaki reviews how the involvement of private equity in American healthcare leads to, among other negative outcomes, burnout and stress among healthcare workers, particularly physicians. She writes that the consequences could cripple America’s healthcare system.

What Is Democracy Beyond Elections?

The following is an excerpt from Natasha Piano's new book, Democratic Elitism: The Founding Myth of American Political Science, now out at Harvard University...

The Antitrust Agencies Should Block OpenAI’s Windsurf Acquisition To Support AI Innovation

Recent government wins against Big Tech demonstrate the prudence of proactively stopping consolidation in the emerging AI startup ecosystem to prevent harm to innovation and consumers. OpenAI’s recent acquisition of Windsurf raises these competition concerns. The antitrust agencies should block it.

Does Private Equity Harm the Welfare of Residents in Nursing Homes?

Robert I. Field argues that private equity’s impact on price competition among nursing homes is limited because prices are mostly determined by Medicaid. However, private equity does impact quality and labor outcomes, which deserve greater government scrutiny.

Does Private Equity Harm Competition in the Hospital Industry?

Brent Fulton discusses private equity’s investments in hospitals and assesses the risks it presents to key stakeholders: private equity investors, debt investors, patients, and the government. He argues financial transparency regulation is needed so fraudulent transfer and bankruptcy laws can be enforced to reduce uncompensated risk being borne by patients and the government (ultimately taxpayers).

Do Private Equity and Other Investors Harm Competition in the Pharmaceutical Industry?

Melissa Newham reviews how investors can alter the incentives and behavior of pharmaceutical companies to reduce competition and consumer welfare through common ownership and “rollup” deals.

Behind Populists’ Anti-Technocratic Fervor and Its Consequences for Liberal Democracy

Populist leaders like United States President Donald Trump are zealously challenging the authority of independent technocrats and judges. This backlash follows decades of steadily increasing delegation of policymaking authority to unelected experts, bureaucratic agencies, and the judiciary. In new research, Gabriele Gratton and Jacob Edenhofer argue that such backlash is a predictable development in political environments where majorities are unstable and new political coalitions frequently favor policies at odds with those crafted by social welfare-maximizing technocrats.

The Curious Case of Private Equity in Health Care’s Market Failures

Over the last year, the United States government has demonstrated increased concern about private equity’s involvement in health care. Barak Richman and Richard Scheffler...

Antitrust Should Be a Tool for Creating Abundance

In the wake of Democrats’ losses in 2024, progressives should focus on how antitrust can support a lower cost of living and increase consumer access to essential goods and services, writes Diana Moss.

The Deafening Silence of Big Business in Washington

Wendy Li writes that business leaders must rediscover past unity and put pressure on politicians to defend against President Donald Trump’s attacks on businesses and civil society and prevent democratic backsliding.

Latest news